Natural Immunity Explains Decline in Cases
As noted by Kaplan, the most reasonable explanation for declining rates of SARS-CoV-2 appears to be natural immunity from previous infections, which vary considerably from state to state.7 He goes on to cite a study8 by the National Institutes of Health, which suggests SARS-CoV-2 prevalence was 4.8 times higher than previously thought, thanks to undiagnosed infection.
In other words, they claim that for every reported positive test result, there were likely nearly five additional people who had the infection but didn’t get a diagnosis. To analyze this data further, Kaplan calculated the natural immunity rate by dividing the new estimated number of people naturally infected by the population of any given state. He writes:9
“By mid-February 2021, an estimated 150 million people in the U.S. (30 million times five) may have had been infected with SARS-CoV-2. By April, I estimated the natural immunity rate to be above 55% in 10 states: Arizona, Iowa, Nebraska, North Dakota, Oklahoma, Rhode Island, South Dakota, Tennessee, Utah, and Wisconsin.
At the other end of the continuum, I estimated the natural immunity rate to be below 35% in the District of Columbia, Hawaii, Maine, Maryland, New Hampshire, Oregon, Puerto Rico, Vermont, Virginia, and Washington …
By the end of 2020, new infections were already rapidly declining in nearly all of the 10 states where the majority may have had natural immunity, well before more than a minuscule percentage of Americans were fully vaccinated. In 80% of these states, the day when new cases were at their peak occurred before vaccines were available.
In contrast, the 10 states with lower rates of previous infections were much more likely to experience new upticks in Covid-19 cases in March and April ... By the end of May, states with fewer new infections had significantly lower vaccination rates than states with more new infections.”
COVID Shots Cannot Eliminate COVID-19
So, SARS-CoV-2 cases were actually higher in states where natural immunity was low but vaccination rates were high. Meanwhile, in states where natural immunity due to undiagnosed exposure was high, but vaccination rates were low, the daily new caseload was also lower.
This makes sense if natural immunity is highly effective (which, historically it has always been and there’s no reason to suspect SARS-CoV-2 is any different in that regard). It also makes sense if the COVID shots aren’t really offering any significant protection against infection, which we also know is the case.
Vaccine manufacturers have already admitted these COVID shots will not provide immunity, meaning they will not prevent you from being infected. The idea behind these gene modification injections is that if/when you do get infected, you’ll hopefully experience milder symptoms, even though you’re still infectious and can spread the virus to others.
Kaplan ends his analysis by saying that COVID shots are a safer way to achieve herd immunity, and that they are “the best tool available for assuring that the smoldering fire of [COVID-19] is extinguished.” I disagree, based on two major issues.
First, and perhaps most importantly, this is an untested “vaccine” and we have no idea of the short-term let alone long-term damage it will cause, as any reasonable effort at collecting this data has been actively suppressed. Secondly, the survivability of COVID-19 outside of nursing homes is 99.74%. If you’re under the age of 40, your chance of surviving a bout of COVID-19 is 99.99%.10,11,12
You can’t really improve your chances of surviving beyond that, so COVID shots cannot realistically end the pandemic. Meanwhile, the COVID shots come with an ever-growing list of potential side effects that can take years if not decades off your natural life span. The shots are particularly unnecessary for anyone with natural immunity,13 yet that’s what the CDC recommends.14
Why Push COVID Jab on Those with Natural Immunity?
In January 2021, Dr. Hooman Noorchashm, a cardiac surgeon and patient advocate, sent a public letter15 to the U.S. Food and Drug Administration commissioner detailing the risks of vaccinating individuals who have previously been infected with SARS-CoV-2, or who have an active SARS-CoV-2 infection.
He urged the FDA to require prescreening for SARS-CoV-2 viral proteins to reduce the risk of injuries and deaths following vaccination, as the vaccine may trigger an adverse immune response in those who have already been infected with the virus. In March 2021, Fox TV host Tucker Carlson interviewed him about these risks. In that interview, Noorchashm said:16
“I think it’s a dramatic error on part of public health officials to try to put this vaccine into a one-size-fits-all paradigm … We’re going to take this problem we have with the COVID-19 pandemic, where a half-percent of the population is susceptible to dying, and compound it by causing totally avoidable harm by vaccinating people who are already infected …
The signal is deafening, the people who are having complications or adverse events are the people who have recently or are currently or previously infected [with COVID]. I don’t think we can ignore this.”
In an email to The Defender, Noorchashm fleshed out his concerns, saying:17
“Viral antigens persist in the tissues of the naturally infected for months. When the vaccine is used too early after a natural infection, or worse during an active infection, the vaccine force activates a powerful immune response that attacks the tissues where the natural viral antigens are persisting. This, I suggest, is the cause of the high level of adverse events and, likely deaths, we are seeing in the recently infected following vaccination.”
Despite being widely ignored, Noorchashm continues to push for the implementation of prevaccine screening using PCR or rapid antigen testing to determine whether the individual has an active infection, and an IgG antibody test to determine past infection.
If either test is positive, he recommends delaying vaccination for a minimum of three to six months to allow your IgG levels to wane. At that point, he recommends testing your blood IgG level and use that as a guide to decide the timing of your vaccination.